Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation.
Parlato M,Charbit-Henrion F,Abi Nader E,Begue B,Guegan N,Bruneau J,Khater S,Macintyre E,Picard C,Frédéric R,Le Bourhis L,Allez M,Goulet O,Cellier C,Hermine O,Cerf-Bensussan N,Malamut G
Source :
Gastroenterology
2018 Déc 15
Pmid / DOI:
30557559
Abstract
KEYWORDSAutoimmune Enteropathy, Immune Regulation, JAK1/2 Inhibitor, Monogenic Disorders